Gilead Sciences Announces Second Quarter 2018 Dividend

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared a cash dividend of $0.57 per share of common stock for the second quarter of 2018. The dividend is payable on June 28, 2018, to stockholders of record at the close of business on June 15, 2018. Future dividends will be subject to Board approval.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180501006178/en/

Investors
Gilead Sciences, Inc.
Robin Washington, 650-522-5688
Sung Lee, 650-524-7792

Source: Gilead Sciences, Inc.

You May Also Be Interested In

• EU approves Gilead's Trodelvy for first-line metastatic TNBC
• First Farmers and Merchants Corporation Declares Quarterly Cash Dividend of $0.29 Per Share
• Pet Valu Holdings Ltd. (PET) Closes the Market